Exopolysaccharides (EPSs) produced by lactic acid bacteria (LAB) have received special attention as valuable products due to their potential applications as techno-functional and bioactive ingredients in foods. EPS production and consumption are an age-old practice in humans, as evidenced by fermented foods. Over the last two decades, extensive research has examined, analyzed, and reported a wide variety of EPSs from several LAB strains, as well as their techno-functional properties in foods. Also, research efforts focused on EPS characterization and yield production have been carried out. In food applications, EPS quantification and characterization in situ (direct fermentation) took place in various matrices (dairy, bread, plant-based fermented, and meat products). EPS direct application (ex situ) has been less investigated despite its better structural–functional control and use in non-fermented foods. Fewer EPS investigations have been conducted related to health benefits in humans and their mechanisms of action. The composition and functionality of EPSs vary depending on the LAB strain and food matrix used to produce them; thus, various challenges should be addressed before industrial applications are performed. This review aims to compile and summarize the recent findings on EPSs produced by LAB, highlighting their yield, culture production, techno-functional role in foods, food applications, and health benefits in clinical trials. It examines their dual applications, whether as purified functional ingredients (ex situ) or as fermentation products (in situ), and critically assesses both technological and bioactive implications. Also, it explores production challenges, regulatory considerations, and future perspectives for sustainable and tailored applications of EPSs in food innovation.
Hernández‐Figueroa et al. (2025) studied this question.